Knightscope aims for a January 27th NASDAQ listing, offering investors a last chance to participate before the IPO.

Napo Pharmaceuticals launches a pilot study on Crofelemer, aiming to improve the lives of Short Bowel Syndrome patients.

An analysis of Lowe's performance amid economic challenges, examining sales trends, financial health, and investment outlook.

A simplified approach to reading cash flow statements, using Apple’s financials as a guide.